|
New Clinically Researched Weight Management Nutraceutical Provides Dramatic Improvements in Weight-Related Health Benefits DygloFit™ Supports a Trim and Healthy Body The Icon Group is one of America's largest providers of proprietary, clinically tested, "weight wellness" nutraceutical ingredients which combine significant weight management properties with health-enhancing, weight-related metabolic wellness benefits in a comprehensive manner. For overweight people, this multifunctional approach is vital for maintaining optimum health because metabolic dysfunction is so closely tied to weight gain. That's why we have introduced clinically tested DygloFit™, a market leader that is one of the most comprehensive, efficacious and multi-dimensional weight management and metabolic wellness nutraceuticals available today. DygloFit™ is an Advanced "Weight Wellness" Nutraceutical
DygloFit™ is an all natural, GRAS-affirmed, standardized extract of
Dichrostachys glomerata
fruit. This fruit has a long history of use as a culinary spice and for medicinal purposes in its native West Africa. Patented DygloFit™ (U.S. Patent
# 8,361,523) contains polyphenol bioactives that help provide healthy weight management and metabolic wellness benefits ("weight wellness") via multiple mechanisms of action. These types of polyphenols may help enhance insulin sensitivity allowing more blood sugar to be used for energy and less converted to fat. DygloFit™ bioactives provide superior antioxidant protection which helps support cardiovascular health. In addition, research has shown these types of polyphenols possess anti-inflammatory properties which helps provide resistance to challenges associated with metabolic dysfunction.
A "Gold Standard" Human Clinical Trial has Demonstrated DygloFit's
Superior Healthy Weight Management and Metabolic Wellness Properties
DygloFit's superior health benefits were demonstrated in an 8-week long, "Gold Standard", double-blind, placebo-controlled human clinical trial involving 297 subjects. Participants took the recommended dose of DygloFit™ or placebo before lunch and dinner and were instructed to not alter their diet or level of exercise. There were significant health improvements at both 4 and 8 weeks. By Week 8, subjects taking DygloFit™ lost an average of 24.5 lbs. and 11.3% body fat, and had significant reductions in waist (-4.2") and hip (-3.5") size. Factors associated with metabolic dysfunction also improved, including blood lipids, fasting blood sugar and insulin sensitivity, inflammation, and blood pressure. These results demonstrate that DygloFit™ helps support healthy weight management and metabolic wellness in a comprehensive manner. DygloFit™ is a Superior Choice New clinically tested DygloFit™ patented nutraceutical has the scientific support and regulatory substantiation to excel as a superior "weight wellness" nutraceutical, addressing both weight management and metabolic wellness in a comprehensive manner. It offers a superior choice to marketers looking to develop new weight-related dietary supplement products.
to learn more about DygloFit™ and the multiple
ways it be positioned to enhance your bottom line.
167 Main Street #208, Brattleboro, Vermont 05301
Telephone: 802. 257. 5345 · Fax: 802. 251. 6981 · info@icongroupllc.com *These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any disease. |
